Global Plasma Fractionation Market: Driven by Chronic Disease Prevalence, Surging at a CAGR of 10.6%

"Anticipating growth fueled by increasing prevalence of immuno-deficiency disorders and the rising demand for immunoglobulins, the plasma fractionation market prepares for major strides in healthcare.

What Is The Projected Market Size Of The Global Plasma Fractionation Market And Its Growth Rate?
• The plasma fractionation market size which grew to $31.42 billion in 2024 is slated to reach $34.44 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%.
• The current market growth owes to increased incidences of hemophilia and immunodeficiency disorders among the aging population, the demand for immunoglobulins and expansion of plasma collection centers.
• The market is projected to grow significantly to reach $51.56 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%.
• This predicted growth is based on the rise in global healthcare expenditure, growing applications of plasma-derived medicinal products, and increasing investment in research and development.

What Is Driving The Growth In The Plasma Fractionation Market?
Driven by the increasing prevalence of chronic diseases and thereby, the growing need for plasma products, the plasma fractionation market's growth momentum is set. Utilizing plasma products in the treatment of chronic diseases like heart disease, cancer, and diabetes reduces morbidity, improves the quality of life, and proves to be cost-effective. The projection of an increase in the number of individuals aged 50 years and older having one or more chronic illnesses by 99.5% by 2050, reinforces the expected growth of the plasma fractionation market.

Request A Free Sample Copy: https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

Who Are the Key Players Driving Plasma Fractionation Market Growth?
• Baxter International Inc.
• Bio Products Laboratory Limited
• Biotest AG
• CSL Limited
• Grifols S. A
• ADMA Biologics Inc.
• Green Cross Corporation
• Hualan Bioengineering Inc.
• Intas Pharmaceuticals Ltd.
• Japan Blood Products Organization
• Kedrion S. P. A.
• Kamada Ltd.
• LFB Biomedicaments S. A. S
• Octapharma AG
• Sanquin Plasma Products B. V.
• Shanghai Raas Blood Products Co. Ltd.
• Takeda Pharmaceutical Company
• Terumo BCT
• China Biologic Products Holdings Inc.
• China National Biotec Group
• Emergent BioSolutions Inc.
• Bharat Serum Vaccines Limited
• Plasma Therapeutics
• Prothya Biosolutions B. V.
• BioPharma Plasma LLC
• BioLife Plasma Services LP

What Are The Key Trends In The Plasma Fractionation Market?
• Development of new fractionation technologies.
• Shift towards albumin and immunoglobulin therapies.
• Rising demand for specialty plasma products.
• Focus on pathogen inactivation technologies.
• Strategic collaborations and partnerships in the plasma industry.

What Are The Segments Of The Global Plasma Fractionation Market?
• By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors.
• By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology.
• By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes.

Which Region Leads The Plasma Fractionation Market?
North America was the largest region in the plasma fractionation market in 2024, with Asia-Pacific expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Pre-book the Report for Swift Delivery: https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

What Is Covered In The Plasma Fractionation Market Global Market Report?
- Market Size Analysis: Analyze the Plasma Fractionation Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Plasma Fractionation Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Plasma Fractionation Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Plasma Fractionation Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Request Customization for This Report: https://www.thebusinessresearchcompany.com/Customise?id=7543&type=smp

Learn More About The Business Research Company
From 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, in-depth secondary research capacity, and unique insights from industry leaders, we ensure you have the information to stay ahead. The Global Market Model (GMM), our flagship product, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company
• Twitter: https://twitter.com/tbrc_info
• YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

This release was published on openPR.